Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions

Ana Carina Silva, Daniel Simão, Claudia Küppers, Tanja Lucas, Marcos F Q Sousa, Pedro Cruz, Manuel J T Carrondo, Stefan Kochanek, Paula M. Alves

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recombinant adenovirus vectors (AdVs) have been used for the development of vaccines, as gene therapy vectors and for protein production. Currently, the production of clinical grade batches of recombinant E1-deleted adenovirus type 5 vectors is performed using human-derived HEK293 or PER.C6® cell lines. In this work we describe the generation of a new human amniocyte-derived cell line named 1G3 and show that it can be used as a very promising cell host for AdV production in serum-free conditions, allowing for production in high cell density cultures and avoiding the typical cell density effect observed for HEK293. By design, this cell line makes the generation of replication-competent adenovirus during production of E1-deleted AdVs very unlikely. The impact of the culture system (static versus agitated) and AdV infection parameters such as multiplicity of infection, time of harvesting and cell concentration at infection were evaluated and compared with HEK293. Using stirred tanks bioreactors, it was possible to grow 1G3 cells to cell densities of up to 9 × 106 cells/mL using serum-free media. Moreover, without a medium exchange step at infection, a three-fold increase in AdV volumetric titers was obtained, as no cell density effect was observed at CCI 3. Overall, our results clearly demonstrate the potential of the human amniocyte-derived newly established cell line 1G3 for AdV production in a serum-free scalable process, paving the way for further process improvements based on fed-batch or perfusion strategies.

Original languageEnglish
Pages (from-to)760-771
Number of pages12
JournalBiotechnology Journal
Volume10
Issue number5
DOIs
Publication statusPublished - 1 May 2015

Fingerprint

Adenoviridae
Cell Count
Cell Line
Infection
Serum
Serum-Free Culture Media
Bioreactors
Genetic Therapy
Vaccines
Cell Culture Techniques
Perfusion
Proteins

Keywords

  • Adenovirus vectors
  • Human amniocyte cells
  • Replication-competent adenovirus
  • Serum-free medium
  • Suspension culture

Cite this

Silva, Ana Carina ; Simão, Daniel ; Küppers, Claudia ; Lucas, Tanja ; Sousa, Marcos F Q ; Cruz, Pedro ; Carrondo, Manuel J T ; Kochanek, Stefan ; Alves, Paula M. / Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions. In: Biotechnology Journal. 2015 ; Vol. 10, No. 5. pp. 760-771.
@article{412211f814ec4087ad61b55cca379088,
title = "Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions",
abstract = "Recombinant adenovirus vectors (AdVs) have been used for the development of vaccines, as gene therapy vectors and for protein production. Currently, the production of clinical grade batches of recombinant E1-deleted adenovirus type 5 vectors is performed using human-derived HEK293 or PER.C6{\circledR} cell lines. In this work we describe the generation of a new human amniocyte-derived cell line named 1G3 and show that it can be used as a very promising cell host for AdV production in serum-free conditions, allowing for production in high cell density cultures and avoiding the typical cell density effect observed for HEK293. By design, this cell line makes the generation of replication-competent adenovirus during production of E1-deleted AdVs very unlikely. The impact of the culture system (static versus agitated) and AdV infection parameters such as multiplicity of infection, time of harvesting and cell concentration at infection were evaluated and compared with HEK293. Using stirred tanks bioreactors, it was possible to grow 1G3 cells to cell densities of up to 9 × 106 cells/mL using serum-free media. Moreover, without a medium exchange step at infection, a three-fold increase in AdV volumetric titers was obtained, as no cell density effect was observed at CCI 3. Overall, our results clearly demonstrate the potential of the human amniocyte-derived newly established cell line 1G3 for AdV production in a serum-free scalable process, paving the way for further process improvements based on fed-batch or perfusion strategies.",
keywords = "Adenovirus vectors, Human amniocyte cells, Replication-competent adenovirus, Serum-free medium, Suspension culture",
author = "Silva, {Ana Carina} and Daniel Sim{\~a}o and Claudia K{\"u}ppers and Tanja Lucas and Sousa, {Marcos F Q} and Pedro Cruz and Carrondo, {Manuel J T} and Stefan Kochanek and Alves, {Paula M.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1002/biot.201400765",
language = "English",
volume = "10",
pages = "760--771",
journal = "Biotechnology Journal",
issn = "1860-6768",
publisher = "John Wiley & Sons, Ltd",
number = "5",

}

Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions. / Silva, Ana Carina; Simão, Daniel; Küppers, Claudia; Lucas, Tanja; Sousa, Marcos F Q; Cruz, Pedro; Carrondo, Manuel J T; Kochanek, Stefan; Alves, Paula M.

In: Biotechnology Journal, Vol. 10, No. 5, 01.05.2015, p. 760-771.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions

AU - Silva, Ana Carina

AU - Simão, Daniel

AU - Küppers, Claudia

AU - Lucas, Tanja

AU - Sousa, Marcos F Q

AU - Cruz, Pedro

AU - Carrondo, Manuel J T

AU - Kochanek, Stefan

AU - Alves, Paula M.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Recombinant adenovirus vectors (AdVs) have been used for the development of vaccines, as gene therapy vectors and for protein production. Currently, the production of clinical grade batches of recombinant E1-deleted adenovirus type 5 vectors is performed using human-derived HEK293 or PER.C6® cell lines. In this work we describe the generation of a new human amniocyte-derived cell line named 1G3 and show that it can be used as a very promising cell host for AdV production in serum-free conditions, allowing for production in high cell density cultures and avoiding the typical cell density effect observed for HEK293. By design, this cell line makes the generation of replication-competent adenovirus during production of E1-deleted AdVs very unlikely. The impact of the culture system (static versus agitated) and AdV infection parameters such as multiplicity of infection, time of harvesting and cell concentration at infection were evaluated and compared with HEK293. Using stirred tanks bioreactors, it was possible to grow 1G3 cells to cell densities of up to 9 × 106 cells/mL using serum-free media. Moreover, without a medium exchange step at infection, a three-fold increase in AdV volumetric titers was obtained, as no cell density effect was observed at CCI 3. Overall, our results clearly demonstrate the potential of the human amniocyte-derived newly established cell line 1G3 for AdV production in a serum-free scalable process, paving the way for further process improvements based on fed-batch or perfusion strategies.

AB - Recombinant adenovirus vectors (AdVs) have been used for the development of vaccines, as gene therapy vectors and for protein production. Currently, the production of clinical grade batches of recombinant E1-deleted adenovirus type 5 vectors is performed using human-derived HEK293 or PER.C6® cell lines. In this work we describe the generation of a new human amniocyte-derived cell line named 1G3 and show that it can be used as a very promising cell host for AdV production in serum-free conditions, allowing for production in high cell density cultures and avoiding the typical cell density effect observed for HEK293. By design, this cell line makes the generation of replication-competent adenovirus during production of E1-deleted AdVs very unlikely. The impact of the culture system (static versus agitated) and AdV infection parameters such as multiplicity of infection, time of harvesting and cell concentration at infection were evaluated and compared with HEK293. Using stirred tanks bioreactors, it was possible to grow 1G3 cells to cell densities of up to 9 × 106 cells/mL using serum-free media. Moreover, without a medium exchange step at infection, a three-fold increase in AdV volumetric titers was obtained, as no cell density effect was observed at CCI 3. Overall, our results clearly demonstrate the potential of the human amniocyte-derived newly established cell line 1G3 for AdV production in a serum-free scalable process, paving the way for further process improvements based on fed-batch or perfusion strategies.

KW - Adenovirus vectors

KW - Human amniocyte cells

KW - Replication-competent adenovirus

KW - Serum-free medium

KW - Suspension culture

UR - http://www.scopus.com/inward/record.url?scp=84928784448&partnerID=8YFLogxK

U2 - 10.1002/biot.201400765

DO - 10.1002/biot.201400765

M3 - Article

VL - 10

SP - 760

EP - 771

JO - Biotechnology Journal

JF - Biotechnology Journal

SN - 1860-6768

IS - 5

ER -